IEX •
Healthcare •
Biotechnology •
Quote as of 09/11/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization207.33 mln
Float17.35 mln
Earnings Date12/01/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
3.58
Highly suspicious
Relative Strength
16
/ 100
Significantly lagging
Debt / Equity
0.00
Debt-free
Pre-Tax Margin
-154%
Severely loss-making
ROE
-49.09
Deeply negative
Business Description
Alpha Cognition Inc. is a Canadian drug development company focused on finding new ways to treat brain diseases like Alzheimer's and other conditions that cause the nervous system to break down. Its main product, ZUNVEYL, is an approved oral tablet used to treat Alzheimer's disease, with ongoing research into combining it with other medicines to help patients with more advanced stages of the condition. The company is also exploring treatments for acute pancreatitis, brain injuries, and serious conditions like ALS and spinal muscular atrophy.
